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Abstract
Background: Presumptive treatment of malaria in febrile children is widely advocated in Africa.
This may occur in the absence of diagnostic testing or even when diagnostic testing is performed
but fails to detect malaria parasites. Such over-treatment of malaria has been tolerated in the era
of inexpensive and safe monotherapy. However, with the introduction of new artemisinin-based
combination therapy (ACT), presumptive treatment becomes economically and clinically less
acceptable.
Methods: The risks and benefits of only treating children with microscopy confirmed malaria using
a prospective cohort design were investigated. A representative sample of 601 children between
one and 10 years of age were recruited from a census population in Kampala, Uganda and were
followed for all of their health care needs in a study clinic. Standard microscopy was performed
each time a child presented with a new episode of fever and antimalarial therapy given only if the
blood smear was positive.
Results: Of 5,895 visits for new medical problems 40% were for febrile illnesses. Of the 2,359
episodes of new febrile illnesses, blood smears were initially reported as negative in 1,608 (68%)
and no antimalarial therapy was given. Six of these initially negative smears were reported to be
positive following quality control reading of all blood smears: four of these patients were
subsequently diagnosed with uncomplicated malaria and two cleared their parasites without
antimalarial treatment. Of the 1,602 new febrile illnesses in which the final blood smear reading was
classified as negative, only 13 episodes (0.8%) were diagnosed with malaria in the subsequent 7 days.
All 13 of these episodes of malaria were uncomplicated and were successfully treated.
Conclusion: In this urban setting, malaria was responsible for only 32% of febrile episodes.
Withholding antimalarial therapy in febrile children with negative blood smears was safe and saved
over 1,600 antimalarial treatments in 601 children over an 18-month period. In the era of expensive
ACT, directing resources towards improving diagnostic and treatment practices may provide a
cost-effective measure for promoting rational use of antimalarial therapy.
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The practice of presumptive treatment of malaria has been
widely advocated in sub-Saharan Africa as a means of
increasing antimalarial coverage and reducing the risk of
progression to severe disease and death. However, it is
well known that such practice frequently results in the
unnecessary use of antimalarials, especially in lower trans-
mission settings and older patient populations [1,2]. Such
over-treatment of malaria has been tolerated in the era of
inexpensive and safe antimalarial drugs such as chloro-
quine. However, due to the spread of drug resistance,
many African countries are moving to artemisinin-based
combination therapy (ACT) where presumptive treatment
becomes economically and clinically less acceptable. In
this new era of ACT, there has been an increased emphasis
on antimalarial treatment based on laboratory confirma-
tion [3].
Microscopy remains the gold standard for laboratory con-
firmation of malaria and its use could provide an efficient
and cost effective means of significantly reducing the
number of unnecessary antimalarial treatments [4]. How-
ever, there is evidence that the results of microscopy may
have limited impact on antimalarial treatment practices
even when the blood smear is negative [5,6]. Indeed, the
most recent antimalarial treatment guidelines from
Uganda recommend "any patient with fever or history of
fever within the last 24 hours without evidence of other
diseases should be treated for malaria even with a negative
blood smear for malaria parasites" [7]. One potential fac-
tor contributing to the practice of prescribing antimalarial
therapy in the setting of a negative blood smear is the
belief that patients may still have malaria and lack of anti-
malarial treatment will lead to a poor outcome. In this
study, we investigated the risks and benefits of giving anti-
malarial treatment only when confirmed by microscopy
in a cohort of 601 Ugandan children aged 1–10 years liv-
ing in a meso-endemic area followed prospectively for all
of their health care needs over an 18 month period.
Methods
Description of study site and recruitment of study 
participants
This study was conducted in Kampala, the capital of
Uganda, with an estimated population of 1.2 million.
Malaria is meso-endemic in this area (parasite prevalence
17% among children) [8], occurring throughout the year
with two peaks during the rainy seasons from March-May
and September-November. Data from this study comes
from a representative cohort of 601 children aged 1 to 10
years recruited as part of a primary longitudinal clinical
trial of antimalarial therapy. Details of the screening and
recruitment of this cohort have been published previously
[9]. Briefly, a census was performed in a geographically
defined urban slum adjacent to our study clinic. Children
were recruited from this census population using proba-
bility sampling if they fulfilled all of the following eligibil-
ity criteria: 1) age 1 to 10 years, 2) agreement to come to
the study clinic for any febrile episode or other illness, 3)
agreement to remain in Kampala for the duration of the
study, 4) agreement to avoid medications administered
outside the study protocol, 5) weight ≥ 10 kg, 6) absence
of severe malnutrition, 7) absence of known serious
chronic diseases requiring frequent medical attention (e.g.
AIDS, sickle cell disease, malignancy), 8) absence of life-
threatening screening laboratory results, and 9) willing-
ness of parents or guardians to provide informed consent.
Enrollment took place between November 2004 and April
2005.
Follow-up of study participants
Participants were followed up at a designated study clinic
located in the outpatient department of Mulago Hospital,
the primary referral hospital in Uganda. Parents/guardi-
ans were asked to bring their child to the study clinic for
all of their medical care. The study clinic was open daily
from 8:00 am to 5:00 pm and after-hours care was availa-
ble at Mulago Hospital.
Children who presented to the study clinic with new med-
ical problems underwent a standardized medical evalua-
tion. Subjects who were febrile (tympanic temperature ≥
38.0°C) or reported history of fever in the previous 24
hours had blood obtained by fingerprick for a thick blood
smear. If the thick blood smear was positive, the patient
was diagnosed with malaria regardless of the parasite den-
sity. Patients with uncomplicated malaria were given
directly observed therapy with one of three combination
antimalarial regimens under evaluation. Patients with
severe malaria [10] or danger signs [11] were treated with
quinine. Patients diagnosed with malaria and other con-
comitant febrile illnesses were treated for both. If the thick
blood smear was negative the patient was not given anti-
malarial therapy and managed at the discretion of the
study physicians. Standardized treatment algorithms were
developed to help guide therapy for non-malarial ill-
nesses. Medications with antimalarial activity were
avoided for the treatment of non-malarial illnesses,
including tetracyclines, antifolates, and macrolide antibi-
otics, when acceptable alternatives are available. Anti-
helminths and Vitamin A were routinely prescribed as per
the Integrated Management of Childhood Illnesses
(IMCI) guidelines. When necessary, participants were
referred to the appropriate facility within the Mulago Hos-
pital complex.
Study participants were encouraged to visit the Mulago
Hospital pediatric emergency department when urgent
care was needed outside of study clinic hours. Participants
were instructed to inform emergency department person-Page 2 of 8
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tration and to visit the study clinic on the following day.
Identified Mulago Hospital personnel were educated
about the study protocol and a nurse, employed by the
project, oversaw adherence to the study protocol.
Children were evaluated for routine assessment if approx-
imately 30 days elapsed without having a blood smear
obtained. These routine assessments were made to ensure
compliance with the study protocol and obtain blood
smears for the evaluation of asymptomatic parasitaemia.
Microscopy
Thick blood smears were stained with 2% Giemsa for 30
minutes. Parasite density was estimated by counting the
number of asexual parasites per 200 white blood cells and
calculating parasites per μL, assuming a white blood cell
count of 8,000 cells per μL. A smear was judged to be neg-
ative if no parasites were seen after review of 100 high
powered fields. The diagnosis and management of
malaria was based on initial readings of blood smears.
Final microscopy results were based on a rigorous quality
control system which included a second microscopist re-
reading all blood smears and any discrepancies between
the first and second readings resolved by a third micro-
scopist.
Ethical approval and data management
Written informed consent was obtained from the parents/
guardians of children for their participation in the study.
Ethical approval was obtained from the Uganda National
Council of Science and Technology, the Makerere Univer-
sity Research and Ethics Committee, and the University of
California, San Francisco Institutional Review Board.
Data were double-entered in Access (Microsoft Corpora-
tion, Redmond, WA) and statistical analysis was per-
formed using Stata version 8 (Stata, College Station, TX,
USA). Categorical variables were compared using the chi-
square test. A p-value of < 0.05 was considered statistically
significant.
Results
Baseline characteristics of the study participants
A detailed description of the baseline characteristics of the
601 children enrolled in the cohort have been published
[9]. Briefly, the mean age was 5.8 years, 37% were under
the age of five, and 48% were female. Any bednet use was
reported in 43% of the cohort, but only 6% reported using
an insecticide-treated bednet (ITN). The prevalence of
asymptomatic parasitaemia was 19% and 3% of children
were found to have symptomatic malaria (fever and posi-
tive blood smear) on the day of enrollment.
Follow-up of study participants
A total of 77 children were prematurely excluded from the
study for the following reasons; movement out of Kam-
pala for > 60 days (n = 49), inability to locate child for >
60 consecutive days (n = 12), withdrawal of consent (n =
11), and diagnosis of serious chronic disease requiring fre-
quent medical care (n = 5). Follow-up for the remaining
524 patients continued until May-June 2006, at which
time ITNs were distributed to the entire cohort. The cumu-
lative follow-up period for the cohort was 740 person
years, which constituted 93% of the potential follow-up
time.
Study clinic visits for new medical problems
A total of 5,895 visits were made to the study clinic for
new medical problems. Among all visits for new medical
problems, 2,359 (40%) were for febrile illnesses (tym-
panic temperature ≥ 38.0°C and/or subjective fever in the
previous 24 hours) (Figure 1). A total of 59 children
(10%) never experienced a febrile episode. In the remain-
ing 542 participants, the median number of visits for new
febrile illnesses was 4 (range 1–16).
Of the 2,359 episodes of new febrile illnesses, 751 (32%)
were associated with an initial positive blood smear, and
the participants were diagnosed and treated for malaria
(Figure 1). None of the 751 initial positive blood smears
were found to be negative after quality control reading
(specificity of initial blood smear reading = 100%). A total
of 270 children (45%) had no episodes of malaria during
the study follow-up. In the remaining 331 participants,
the median number of episodes of malaria was 2 (range
1–12).
Outcomes of febrile illnesses with blood smears negative 
for malarial parasites
In a total of 1,608 episodes of febrile illnesses the initial
blood smear was read as negative and treatment for
malaria was not given. Six of these blood smears were sub-
sequently determined to be positive for malarial parasites
after quality control reading, giving a sensitivity of 99.6%
for the initial blood smear reading (Figure 1). Two of the
patients with false negative initial blood smears readings
had very low parasite densities (16 asexual parasites/μL)
and spontaneously cleared their parasites without antima-
larial treatment. Two of the patients with false negative
blood smears returned the following day with fever and
parasitaemia and were treated successfully for uncompli-
cated malaria. In the remaining two patients with false
negative blood smears, the fever resolved but parasitaemia
persisted until the time they were diagnosed and success-
fully treated for uncomplicated malaria 51 and 61 days
after the false negative blood smear reading, respectively.Page 3 of 8
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Profile of visits made to the study clinic for new medical problemsFigure 1
Profile of visits made to the study clinic for new medical problems. Initial reading of blood smear defined as the first 
reading done in the study clinic that was used for clinical decision making. The final reading of blood smear included reading by 
a second microscopist and reading by a third microscopist if there were discrepancies between the first and second readings.
Microscopy performed as 
part of evaluation in the 
study clinic 
Microscopy not performed 
as part of evaluation in the 
study clinic 
Initial reading of blood smear 
positive for malaria parasites 
n = 751 (32%) 
Initial reading of blood smear 
negative for malaria parasites 
n = 1608 (68%) 
Children diagnosed and 
treated for malaria 
Children not treated for 
malaria and followed up at the 
discretion of study physician 
Final reading of blood smear 
positive (false negative) 
n = 6 (0.4%) 
Final reading of blood smear 
negative (true negative) 
n = 1602 (99.6%) 
Subsequent 7 days of follow-up 
after presentation with fever 
and negative blood smear 
Children diagnosed 
with malaria 
n = 13 (0.8%) 
Children not diagnosed 
with malaria 
n = 1589 (99.2%) 
Spontaneous clearance 




diagnosed and treated 
for malaria 
n = 4 
Child presents with no 
recent subjective fever 
and temperature < 38.0˚C
n = 3536 (60%)
Child presents with recent 
subjective fever or 
temperature > 38.0˚C
n = 2359 (40%)
Visits to study clinic for 
new medical problems 
n = 5895 
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sub-patent parasitaemia, the risk of being diagnosed with
malaria was assessed over the subsequent seven days in
the 1,602 febrile episodes with negative blood smears
(Figure 1). A total of 13 episodes (0.8%) of new febrile ill-
nesses with negative blood smears were diagnosed with
malaria in the subsequent seven days. All 13 of these epi-
sodes of malaria were uncomplicated and successfully
treated. For 10 of these 13 events, the initial illness report-
edly resolved and a new illness had occurred at the time
malaria was diagnosed three to six days later, suggesting
malaria was not the cause of fever at the time the blood
smear was initially read as negative. In the remaining
three events, the initial febrile illness had persisted up
until the time malaria was diagnosed one to five days
later, suggesting malaria was the cause of the fever at the
time the blood smear was initially read as negative. The
incidence of malaria in the seven days following a nega-
tive smear in a febrile patient was significantly lower than
the incidence of malaria over the entire course of the study
(0.42 vs. 1.01 per person year, p = 0.0003).
Diagnosis and treatment of non-malarial febrile illnesses
Data on physicians' diagnoses and treatments for all non-
malarial febrile illnesses based on standardized guidelines
developed locally were systematically collected. Diag-
noses included a wide range of common childhood ill-
nesses. The most common illnesses were upper
respiratory tract infection, common cold, and non-speci-
fied fever (Table 1). Pneumonia, urinary tract infection,
and otitis media occurred less frequently. Younger chil-
dren (less than 5 years of age) were more likely to have
pneumonia, diarrhea, or otitis media as a cause of their
fever compared to those 5 years or older. In contrast,
febrile illness were more likely to be non-specified (with-
out localizing signs or symptoms and primary investiga-
tions yielded negative results) in older children. Most of
the treatments prescribed for nonmalarial febrile illnesses
were for the management of symptoms, including para-
cetamol, cough syrup, and vitamin C (Table 2). Less than
half (45%) received an antibiotic, with amoxicillin being
the most commonly prescribed. Young children were
more likely to receive antibiotics compared to older chil-
dren (56% vs. 44%, p < 0.0001). An antibiotic was pre-
scribed in 96% of patients when the febrile illness was due
to pneumonia, urinary tract infection, or otitis media. In
contrast, only 45% of patients with febrile illnesses due to
upper respiratory tract infections or common colds
received antibiotics and only 28% of patients with non-
specified febrile illnesses received antibiotics.
Risk of severe illnesses
The most important goal of malaria case management is
to prevent the progression to severe disease and death. In
this study we were able to estimate the risk of severe dis-
ease due to malaria and nonmalarial illnesses in a cohort
of Ugandan children receiving free comprehensive care
where malaria was only treated if confirmed by micros-
copy. There were no deaths during the study and no epi-
sodes of severe malaria based on standardized WHO
criteria [10]. There were 16 episodes of malaria accompa-
nied by danger signs [11] and 3 episodes with hyperpara-
sitaemia (> 500,000 asexual parasites/μL) that were
hospitalized and treated with quinine in accordance with
our study protocol. Danger signs included single convul-
sions (n = 12), inability to sit up or stand (n = 2), persist-
ent vomiting (n = 1) and lethargy (n = 1). An additional
22 hospitalizations occurred due to non-malarial illnesses
that included the following; pneumonia (n = 6), fractures
(n = 2), pyomyositis (n = 2), fever of unknown origin (n
= 2), abscess drainage (n = 1), sinusitis (n = 1), febrile con-
vulsions (n = 1), cellulitis (n = 1), severe weakness of
unknown etiology (n = 1), asthma (n = 1), lead poisoning
(n = 1), chickenpox (n = 1), diarrhea (n = 1), and tonsilli-
tis (n = 1).
Discussion
In this study, the risks and benefits of giving antimalarial
treatment for febrile illnesses only when parasitaemia was
confirmed by microscopy were assessed in a cohort of 601
children aged 1–10 years followed over an 18-month
period. Minimal risks of withholding antimalarial treat-
ment in over 1,600 episodes of febrile illnesses with neg-
ative blood smears were observed. In only four cases were
initial blood smears falsely read as negative and children
subsequently diagnosed with uncomplicated malaria. In
another 13 cases, febrile illnesses were possibly due to
sub-patent parasitaemia where children with truly nega-
tive blood smears were diagnosed with uncomplicated
malaria over the subsequent seven days. Thus, only 1% of
cases of febrile illnesses not treated for malaria would
have likely benefited from antimalarial therapy and there
was no evidence that a delay in therapy lead to any serious
adverse outcomes. In contrast, the benefits of withholding
antimalarial therapy in febrile children with negative
blood smears were substantial. The numbers of antimalar-
ial treatments were reduced from 2,359, assuming all
febrile episodes would have been treated presumptively,
to the 751 cases where malaria was confirmed by micros-
copy. Not only did this reduce the risk of adverse conse-
quences associated with unnecessary antimalarial therapy
but allowed clinicians to focus on the true causes of fever,
which were generally mild and self-limiting.
The policy of presumptive treatment of malaria for all
febrile illnesses has been widely advocated in sub-Saharan
Africa, especially in young children. Efforts have been
made to improve the rationale delivery of presumptive
antimalarial therapy through the use of clinical algo-
rithms with limited success [1,12,13]. Thus in the absencePage 5 of 8
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therapy will always be a balance between the potential
benefits of maximizing antimalarial coverage with the
risks of providing unnecessary therapy. In the era of inex-
pensive and safe therapy with chloroquine, it was deemed
economically and clinically acceptable to maximize cover-
age through the promotion of presumptive therapy. How-
ever, many African countries are currently in the process of
changing to ACT as first-line treatment for malaria due to
the spread of resistance to chloroquine and other inexpen-
sive mono-therapies. ACT has been shown to be highly
effective, but due to their increased cost and limited avail-
ability there has been an increased interest in restricting
treatment of malaria to laboratory confirmed cases as a
means of promoting rationale drug use [3].
Light microscopy offers an inexpensive and practical
means of diagnosing malaria. In order to maximize its
impact on antimalarial treatment practices, microscopy
must be available and utilized appropriately, results must
be accurate, and health care providers must use micros-
copy results to guide antimalarial treatment practices in a
rationale way. In this study we did not address the issue of
availability or utilization of microscopy as all febrile chil-
dren were referred for microscopy. In this setting the diag-
nostic accuracy of microscopy was excellent, with a
sensitivity of 99.6% and a specificity of 100%. This excel-
lent microscopy was attributed to having access to good
microscopes, quality staining material, and most impor-
tantly, highly experienced microscopists. Other studies
from Africa in non-research settings have demonstrated
that the diagnostic accuracy of microscopy may not reach
the level obtained in our study, but can achieve acceptable
results. A study done at six health centers in Zambia,
reported fairly good results with an overall sensitivity of
88% and specificity of 91% [6]. In contrast, recent results
from two government health facilities in Kenya reported
an overall sensitivity of 69% and specificity of 62% when
comparing initial microscopy readings to expert micros-
copy readings [14]. These findings underline the impor-
tance of the quality of routine microscopy. Results must
have an acceptable level of accuracy in order for health
care providers to have the confidence to use these results
to make decisions about antimalarial therapy. A national
laboratory survey in Ghana demonstrated that most labo-
ratory staff lacked professional qualifications and there
were marked regional differences in essential resources for
malaria diagnosis [15]. Following a national laboratory
training programme, researchers were able to demonstrate
a modest improvement in the number of laboratories pro-
ducing microscopy results of acceptable quality [15].
If a blood slide is requested it is logical to expect the
results to guide treatment decisions. In this study all pos-
Table 2: The most common treatments prescribed for non-malarial febrile illnesses
Treatments* Total (%) n = 1602 Age < 5 years (%) n = 742 Age ≥ 5 years (%) n = 860 RR† (95%CI) p-value
Paracetamol 1448 (90%) 655 (88%) 793 (92%) 1.0 (1.0–1.2) 0.003
Cough syrups 767 (48%) 394 (53%) 373 (43%) 1.2 (1.1–1.4) 0.0001
Vitamin C 696 (43%) 363 (49%) 333 (39%) 1.3 (1.1–1.4) <0.001
Amoxicillin 457 (29%) 233 (31%) 224 (26%) 1.2 (1.0–1.4)) 0.018
Other antibiotics 332 (21%) 181 (24%) 151 (18%) 1.4 (1.1–1.7) 0.001
Oral rehydration salts 199 (12%) 111 (15%) 88 (10%) 1.5 (1.1–1.9) 0.004
Vitamin A 63 (4%) 35 (5%) 28 (3%) 1.5 (0.9–2.4) 0.134
* Patients may have been given more than one treatment
† RR = Relative risk for age < 5 years versus age ≥ 5 years
Table 1: The most common diagnoses of non malarial febrile illnesses
Diagnoses* Total (%) n = 1602 Age < 5 years (%) n = 742 Age ≥ 5 years (%) n = 860 RR† (95%CI) p-value
Upper respiratory tract infection 754 (47%) 388 (52%) 366 (43%) 1.2 (1.1–1.4) 0.0001
Common cold 469 (29%) 247 (33%) 222 (26%) 1.3 (1.1–1.5) 0.001
Non-specified fever 233 (15%) 86 (12%) 147 (17%) 0.7 (0.5–0.9) 0.002
Pharyngitis/Tonsillitis 196 12%) 76 (10%) 120 (14%) 0.7 (0.6–1.0) 0.028
Diarrhea 157(10%) 95 (13%) 62 (7%) 1.8 (1.3–2.4) 0.0002
Skin infections/wounds 121 (8%) 55 (7%) 66 (7%) 1.0 (0.7–1.4) 0.843
Pneumonia 57(4%) 43 (6%) 14 (2%) 3.6 (2.0–6.5) <0.001
Urinary tract infection 32 (2%) 15 (2%) 17 (0.8%) 1.0 (0.5–2.0) 0.949
Otitis media 22 (1%) 17 (2%) 5 (0.6%) 3.9 (1.5–10.6) 0.003
* Patients may have had more that one diagnosis
† RR = Relative risk for age < 5 years versus age ≥ 5 yearsPage 6 of 8
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malaria. There is little controversy regarding the practice
of giving antimalarial therapy to symptomatic patients
with positive blood smears. However, there are reports of
up to 30% of patients with confirmed malaria not given
antimalarial treatment in rural Tanzania [16]. Such find-
ings raise the question of whether blood smear results
were even being used to influence treatment practices. A
more frequent problem is the practice of giving antimalar-
ial therapy when a blood smear is reported as negative,
especially in low transmission areas and in older patient
populations. In a cross-sectional study from Kenya 79% of
patients over the age of five years with a reported negative
blood smear were given antimalarial therapy [14]. Similar
results have been reported from a low transmission area of
Tanzania where 48% of patients with negative blood
smears were given antimalarial therapy [5] and in Zambia
where 35% of smear negative patients were treated for
malaria [6]. This practice is likely driven by the common
belief that a patient may still have malaria even when the
blood smear is negative, a position which has been pro-
moted by national [7] and international guidelines [17].
In this study, febrile children with negative blood smears
were followed prospectively and their outcomes clearly
showed that there is almost no risk associated with not
providing antimalarial therapy in our setting. The practice
of not giving antimalarial therapy to patients with nega-
tive blood smears has the additional benefit of encourag-
ing health care providers to diagnose the true cause of
their illness. If the true cause of fever is not appropriately
diagnosed, this may result in a delay in introducing
appropriate treatment, especially antibiotics for bacterial
infections, leading to an increased risk of severe complica-
tions and death [18]. The diagnosis of malaria is often
convenient and provides a simple choice for therapy. Fur-
ther research is needed in developing simple diagnostic
and treatment algorithms that can be applied to patients
with non-malaria fevers in resource limited settings of
Africa.
Conclusion
In the era of expensive artemisinin combination therapy,
there is a great need to direct resources toward promoting
the rationale delivery of antimalarial therapy by improv-
ing diagnostic and treatment practices in Africa. In this set-
ting, where malaria transmission was relatively low, the
practice of treating febrile children for malaria only when
the diagnosis was confirmed by microscopy was a safe and
highly effective means of reducing the number of antima-
larial treatments given. The practice of providing antima-
larial therapy when the blood smear is negative in this
patient population is strongly discouraged. In addition,
similar prospective studies to investigate whether such
recommendations are appropriate for other epidemiolog-
ical settings are encouraged.
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